NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P102. A total of 27 filers reported holding NOVABAY PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $4,000 | -77.8% | 13,924 | -51.9% | 0.00% | – |
Q2 2015 | $18,000 | +100.0% | 28,959 | +117.3% | 0.00% | – |
Q1 2015 | $9,000 | -40.0% | 13,328 | -44.0% | 0.00% | – |
Q4 2014 | $15,000 | -77.9% | 23,794 | -72.4% | 0.00% | -100.0% |
Q2 2014 | $68,000 | +88.9% | 86,175 | +309.4% | 0.00% | – |
Q3 2013 | $36,000 | – | 21,047 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GARRISON BRADFORD & ASSOCIATES INC | 138,000 | $170,000 | 0.16% |
BUCKINGHAM STRATEGIC WEALTH, LLC | 56,583 | $70,000 | 0.03% |
EXENCIAL WEALTH ADVISORS, LLC | 59,679 | $71,000 | 0.03% |
Orbitronix, LP | 25,100 | $31,000 | 0.02% |
DRW Securities, LLC | 183,988 | $226,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 121,500 | $149,000 | 0.01% |
EP Wealth Advisors, LLC | 13,267 | $16,000 | 0.00% |
GLENMEDE TRUST CO NA | 300,000 | $369,000 | 0.00% |
KCM INVESTMENT ADVISORS LLC | 23,333 | $29,000 | 0.00% |
BOSTON FAMILY OFFICE LLC | 17,500 | $22,000 | 0.00% |